Knowledge Center
Patent / Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Source:
WO 2013104892
The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.
Also in the Knowledge Center
/ Dec 06, 2017
Effect of throat models and representative deposition profiles on the performance of carrier-based formulations
Read more
Scientific Article
Scientific Article
/ Dec 06, 2017
Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment
Read more
Scientific Article